Development and validation of a sensitive LC-MS/MS method with electrospray ionization using multiple ions for quantitation of torcetrapib in hamster and dog plasma.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biomedical chromotography

• Publication date

  2008-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/BMC.935PMID 18059051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early termination of drug trials

  2007cited by this paper
• A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of rivastigmine in human plasma.

  2007cited by this paper
• Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.

  2007cited by this paper
• The in Vitro Plasma Distribution of a Novel Cholesteryl Ester Transfer Protein Inhibitor, Torcetrapib, Is Influenced by Differences in Plasma Lipid Concentrations

  2006cited by this paper
• Acid-base catalysis of chiral Pd complexes: development of novel catalytic asymmetric reactions and their application to synthesis of drug candidates.

  2006cited by this paper
• Inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

  2006cited by this paper
• Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein: An Initial Multidose Study of Torcetrapib

  2004cited by this paper
• Liquid chromatography-tandem mass spectrometric assay with a novel method of quantitation for the simultaneous determination of bulaquine and its metabolite, primaquine, in monkey plasma.

  2003cited by this paper
• Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis

  2003cited by this paper
• Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid

  2003cited by this paper
• The Yin and Yang of cholesteryl ester transfer protein and atherosclerosis.

  2002cited by this paper
• HDL and arteriosclerosis: beyond reverse cholesterol transport.

  2002cited by this paper
• The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.

  2002cited by this paper
• High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport.

  2001cited by this paper
• Cholesteryl ester transfer protein, high density lipoprotein and arterial disease

  2001cited by this paper
• Low High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart Disease: A Working Group Report

  2001cited by this paper
• 1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis.

  2000cited by this paper
• The SFSTP guide on the validation of chromatographic methods for drug bioanalysis: from the Washington Conference to the laboratory

  1999cited by this paper
• Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables.

  1991cited by this paper

• Simultaneous determination of bendamustine and γ-hydroxybendamustine in mice dried blood spots and its application in a mice pharmacokinetic study.

  2019cites this paper
• Dilemma with Matrix Effect in Bioanalysis – Perspectives from Bioavailability/Bioequivalence Studies for Product Registration?

  2013cites this paper
• Review of the quantitative analysis of cholesteryl ester transfer protein inhibitors.

  2013cites this paper
• Dealing with matrix effect: should there be a cut-off limit for signal ion suppression in quantitative assay validation?

  2011cites this paper
• Sensitivity enhancement in tandem liquid chromatographic mass spectrometric assays by summation of two transition ion pairs--perspectives.

  2009cites this paper
• Sensitivity enhancement and matrix effect evaluation during summation of multiple transition pairs-case studies of clopidogrel and ramiprilat.

  2009cites this paper
• LC/MS/MS analysis of capsaicin using multiple transition pairs-some view points to ponder.

  2009cites this paper
• Torcetrapib for animal and human pharmacokinetic studies: applicability of chiral and achiral methodologies.

  2009cites this paper
• New thinking in the development of novel derivatization reagents for liquid chromatography-mass spectrometric detection.

  2009cites this paper
• Dodging matrix effects in liquid chromatography tandem mass spectrometric assays--compilation of key learnings and perspectives.

  2009cites this paper